Biometric Support by Accelagen from a Data Management Perspective
In the world of clinical trials and maximizing the key outcomes possible, Data Management and Biostatistics are two critical components that often intersect.
Leading contract research organisation offering end-to-end services across strategic consultation, clinical trials, regulatory affairs, biometrics, medical writing, medical affairs and safety management/pharmacovigilance.
You have successfully submitted your enquiry. Someone from our company will respond ASAP
Accelagen: your premier global contract research organization
At Accelagen, we are a leading global contract research organization (CRO) dedicated to co-creating meaningful outcomes that significantly impact the future of human health. Our mission is to provide pharmaceutical and biotech partners with an accelerated, globally recognized pathway to market success.
We leverage our extensive knowledge of international markets to uncover the roadmap to success at every stage of the product lifecycle. Our expert teams in clinical development and regulatory affairs are backed by decades of experience, delivering high-quality data and proven results.
Accelagen employs a distinctive reverse journey mapping approach that builds a comprehensive picture of your end goals. We define your ambitions and key milestones, focusing on what your product will look like on the shelf. By working backwards, we map the steps necessary to achieve market approval, effectively eliminating re-submissions and delays.
As a globally adept CRO, Accelagen offers full study delivery across trial initiation, execution, and completion. Our decades of experience in drug and medical device development, combined with cutting-edge research technology, ensure the highest quality management of preclinical and Phase I-IV trials in accordance with international guidelines.
We customize our operations to deliver success across large multinational clinical trials and smaller single-site trials for specialized therapeutics. Our world-class in-house biometrics services support all clinical trial designs, including randomized controlled, parallel group, crossover, adaptive, retrospective, and prospective studies. Our innovative, user-friendly systems produce accurate, accessible, and reusable data.
With a proven track record of securing hundreds of approvals in Australia and internationally, Accelagen offers clear and accelerated regulatory strategies that maximize the likelihood of approval from the outset. Our experienced team tailors regulatory pathways to align with your strategic objectives, identifying key milestones and potential gaps in regulatory information.
We provide industry-leading guidance on strategic decisions throughout the product lifecycle, ensuring full benefit realization. Our expertise spans regulatory submissions across the globe, including Asia-Pacific, North America, and Europe.
Our regulatory affairs services encompass a comprehensive range of offerings, including the development of tailored regulatory strategies, dossier development and gap analysis, submission publishing and management, and marketing authorization. We also provide expert guidance on product lifecycle management and safety and pharmacovigilance, ensuring that every aspect of your regulatory journey is meticulously addressed to maximize the likelihood of approval and support your strategic objectives.
Accelagen delivers top-tier Biostatistics and Data Management services that prioritize quality outcomes and regulatory compliance. Our in-house capabilities streamline the process of recording, analyzing, and reporting trial data comprehensively. We develop tailored data management solutions that align with the Clinical Data Interchange Standards Consortium (CDISC) best practices, ensuring data accessibility, interoperability, and reusability to meet ever-increasing regulatory standards.
Our unique approach to collaboration and process allows us to work side by side with our partners to co-create meaningful outcomes that impact human health. We provide strategic direction and consultation from concept through commercialization, prioritizing an understanding of your journey and the broader context of your impact.
Our patient-centered, collaborative process draws upon extensive industry experience, enabling you to deliver a comprehensive and robust product to market faster. It’s this innovative approach that sets us apart and enhances the outcomes we generate for you.
Contact us today
Ready to accelerate your journey to market? Use the form above to send us your inquiry, and let’s work together to achieve meaningful outcomes in human health.
In the world of clinical trials and maximizing the key outcomes possible, Data Management and Biostatistics are two critical components that often intersect.
In a pioneering collaboration, Accelagen is joining forces with Griffith University to support a world-first Phase I clinical trial that could revolutionise the treatment of spinal cord injuries (SCI).
Accelagen’s medical team is growing, strengthening our capabilities in pharmacovigilance, medical writing, and clinical oversight for safer, smarter trials.
When it comes to clinical trials, data management practices are critical for ensuring the accuracy and compliance of study results.
As headlines swirl with uncertainty surrounding U.S. agencies like the FDA and Department of Health and Human Services, many pharmaceutical and biotech companies are left questioning the stability of their clinical development pipelines.
Clinical product development continues beyond initial market approval, with ongoing regulatory oversight playing a critical role throughout a product’s lifecycle.
Australian CRO, Accelagen, has established itself as a leader in delivering tailored, high-quality clinical data management solutions.
Regulatory Strategy from Day One: Accelagen’s Approach to Accelerating Global Development
Accelagen represented Australian clinical research on a recent European conference roadshow from OCT Europe in Barcelona to Swiss Biotech Day in Basel.
Accelagen’s approach to site identification and feasibility is setting a new standard for clinical trial operation and management, where strong collaboration and patient needs are prioritised.
Accelagen’s data management team is setting the benchmark for clinical trials by combining global standards, smart technologies, and strong sponsor partnerships. Their commitment to quality ensures faster timelines, cleaner data, and better outcomes.
Amid financial challenges and an evolving regulatory landscape in the US, Accelagen reinforced its position as a stable, strategic partner.
Accelagen’s clinical project leads bring years of hands-on experience managing complex studies, with a key focus on patient outcomes and sponsor success. Their team offers immediate access to expertise with unmatched flexibility.